Joseph H. Griffith, IV net worth and biography

Joseph Griffith, IV Biography and Net Worth

CFO of 908 Devices

Mr. Joe Griffith joins 908 Devices as Chief Financial Officer supporting the development of strategic business plans and financial metrics. Joe brings a 17-year management background in corporate and operational finance, accounting and administration. Most recently he served as Chief Financial Officer for PerkinElmer’s Life Science division. Previously, Joe served in numerous roles for Caliper Life Sciences including Chief Accounting Officer, VP of Finance and Corporate Controller. Joe achieved a BS in Accounting from Villanova University and holds Certified Public Accountant status in Pennsylvania.

What is Joseph H. Griffith, IV's net worth?: The estimated net worth of Joseph H. Griffith, IV is at least $443,874.80 as of February 3rd, 2025. Mr. Griffith, IV owns 109,870 shares of 908 Devices stock worth more than $443,875 as of March 29th. This net worth evaluation does not reflect any other investments that Mr. Griffith, IV may own. Learn More about Joseph H. Griffith, IV's net worth.
How do I contact Joseph H. Griffith, IV?: The corporate mailing address for Mr. Griffith, IV and other 908 Devices executives is , , . 908 Devices can also be reached via phone at 857-254-1500 and via email at ir@908devices.com. Learn More on Joseph H. Griffith, IV's contact information.
Has Joseph H. Griffith, IV been buying or selling shares of 908 Devices?: In the last ninety days, Joseph H. Griffith, IV has sold $23,952.24 in 908 Devices stock. Most recently, Joseph H. Iv Griffith sold 10,236 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $2.34, for a transaction totalling $23,952.24. Following the completion of the sale, the chief financial officer now directly owns 109,870 shares of the company's stock, valued at $257,095.80. Learn More on Joseph H. Griffith, IV's trading history.
Who are 908 Devices' active insiders?: 908 Devices' insider roster includes Nicolas Barthelemy (VP), Trent Basarsky (VP), Christopher Brown (CTO), Joseph Griffith, IV (CFO), John Kenneweg (VP), and Kevin Knopp (CEO). Learn More on 908 Devices' active insiders.
Are insiders buying or selling shares of 908 Devices?: In the last year, 908 Devices insiders bought shares 3 times. They purchased a total of 30,000 shares worth more than $178,500.00. In the last year, insiders at the sold shares 2 times. They sold a total of 19,908 shares worth more than $46,488.00. The most recent insider tranaction occured on February, 3rd when CFO Joseph H Iv Griffith sold 10,236 shares worth more than $23,952.24. Insiders at 908 Devices own 27.7% of the company. Learn More about insider trades at 908 Devices.
Information on this page was last updated on 2/3/2025.

Joseph H. Griffith, IV Insider Trading History at 908 Devices

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/3/2025	Sell	10,236	$2.34	$23,952.24	109,870
2/1/2024	Sell	5,698	$7.00	$39,886.00	89,711
12/19/2023	Sell	5,580	$9.08	$50,666.40	86,000
2/1/2023	Sell	1,836	$9.17	$16,836.12	94,846
8/4/2022	Sell	12,733	$24.39	$310,557.87	91,580
6/27/2022	Sell	5,059	$19.08	$96,525.72	91,580
6/24/2022	Sell	13,129	$19.13	$251,157.77	91,580
6/21/2022	Sell	8,100	$15.06	$121,986.00	91,580
6/17/2022	Sell	900	$15.01	$13,509.00	91,580
6/13/2022	Sell	13,334	$13.54	$180,542.36	91,580
11/5/2021	Sell	2,800	$39.08	$109,424.00
6/16/2021	Sell	17,814	$39.32	$700,446.48	91,580

Joseph H. Griffith, IV Buying and Selling Activity at 908 Devices

908 Devices Company Overview

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $4.04

$3.92

$4.20

50 Day Range

MA: $3.06

$1.98

$4.58

2 Week Range

Now: $4.04

$1.81

$7.56

Volume

816,477 shs

Average Volume

946,703 shs

Market Capitalization

$142.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99